Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F1BUA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,672
Award facts
- Contract value 100% obligated
- $22,672.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,672.47 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 21, 2026. The contract was executed on January 20, 2026, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol and reduce cardiovascular risk, representing a specialty pharmaceutical product within the company's broader medical supply portfolio.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contracting mechanism.
Quick answers
Who was awarded contract SPE2DR26F1BUA?
SPE2DR26F1BUA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F1BUA worth?
The government has obligated $22,672 on SPE2DR26F1BUA.
Is contract SPE2DR26F1BUA an order under another contract?
Yes. SPE2DR26F1BUA is a delivery order under SPE2DR25D2012, an indefinite delivery contract.
Was contract SPE2DR26F1BUA competed?
The extent of competition for SPE2DR26F1BUA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award